CEL-SCI Co. (CVM) Short Interest Update
CEL-SCI Co. (NYSEAMERICAN:CVM) saw a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 583,301 shares, a decrease of 12.8% from the October 13th total of 668,765 shares. Based on an average daily trading volume, of 162,314 shares, the short-interest ratio is currently 3.6 days. Currently, 5.3% of the company’s stock are short sold.
A number of research firms have weighed in on CVM. Dawson James restated a “neutral” rating on shares of CEL-SCI in a report on Monday, October 16th. ValuEngine upgraded CEL-SCI from a “strong sell” rating to a “sell” rating in a report on Monday, August 14th.
Shares of CEL-SCI (NYSEAMERICAN CVM) traded up $0.14 on Monday, hitting $1.82. The stock had a trading volume of 338,400 shares, compared to its average volume of 176,218. CEL-SCI has a 12-month low of $1.46 and a 12-month high of $7.50.
TRADEMARK VIOLATION NOTICE: This story was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/11/13/cel-sci-co-cvm-short-interest-update.html.
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.
Receive News & Ratings for CEL-SCI Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI Co. and related companies with MarketBeat.com's FREE daily email newsletter.